Lensar (LNSR) Cash from Investing Activities (2019 - 2026)
Lensar (LNSR) reported Cash from Investing Activities of $4.0 million for Q1 2026, up 653.3% year-over-year from $531000.0 in Q1 2025, and down 5.77% on a QoQ basis from $4.2 million in Q4 2025.
Lensar (LNSR) has 8 years of Cash from Investing Activities data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 653.3% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 1276.49% YoY) and the FY2025 annual result came in at $1.3 million, up 159.42% from the prior year.
- Cash from Investing Activities declined to $4.0 million in Q1 2026 per LNSR's latest filing, from $4.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.2 million in Q4 2025 and bottomed at -$7.5 million in Q2 2025.
- The 5-year median for Cash from Investing Activities is -$10000.0 (2022), against an average of -$67529.4.
- The widest annual swing landed in 2024, when Cash from Investing Activities sank 45150.0%; it then surged 653.3% in 2026.
- Tracing LNSR's Cash from Investing Activities over 5 years: stood at -$57000.0 in 2022, then plunged by 6856.14% to -$4.0 million in 2023, then soared by 150.24% to $2.0 million in 2024, then surged by 113.1% to $4.2 million in 2025, then retreated by 5.77% to $4.0 million in 2026.
- Per Business Quant, the three latest LNSR Cash from Investing Activities figures stand at $4.0 million (Q1 2026), $4.2 million (Q4 2025), and $4.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 531,000.00 |
| Mar 31, 2025 | 531,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | -905,000.00 |
| Sep 30, 2024 | -905,000.00 |
| Jun 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Dec 31, 2023 | -3.97 Mn |
| Dec 31, 2023 | -3.97 Mn |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -181,000.00 |
| Jun 30, 2023 | -181,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | -57,000.00 |
| Dec 31, 2022 | -57,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -10,000.00 |
| Jun 30, 2022 | -10,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | -156,000.00 |
| Dec 31, 2021 | -156,000.00 |
| Sep 30, 2021 | -64,000.00 |
| Sep 30, 2021 | -64,000.00 |
| Jun 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -20,000.00 |
| Mar 31, 2021 | -114,000.00 |
| Mar 31, 2021 | -114,000.00 |
| Dec 31, 2020 | -105,000.00 |
| Dec 31, 2020 | -105,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | -142,000.00 |
| Jun 30, 2020 | -142,000.00 |
| Mar 31, 2020 | -93,000.00 |
| Mar 31, 2020 | -93,000.00 |
| Dec 31, 2019 | -71,000.00 |
| Dec 31, 2019 | -71,000.00 |